MAP3K14 and Hepatic fibrosis: To determine whether NIK-upregulated cholangiokines stimulate HSCs and liver fibrosis, we treated HSCs with NIK+/+ or NIK−/− cholangiocyte-conditioned medium and measured their expression of fibrosis-related genes.